Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA Mutations [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of TSL-1502 capsules in patients with metastatic breast cancer who have germline BRCA mutations; currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TSL-1502

Snippet

Sponsor: Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. | Conditions: Breast Cancer Metastatic | Phase 2 | Status: RECRUITING